Century Therapeutics Inc. (NASDAQ: IPSC) has appointed Joseph Truitt to its board of directors, bringing extensive experience in scaling biotechnology companies through growth and transition phases. Truitt, who also serves as CEO of iECURE Inc. and chairman of Larimar Therapeutics, previously led BioSpecifics Technologies Corp. as CEO and held senior roles at Achillion Pharmaceuticals, including Chief Commercial Officer and Chief Operating Officer. He also served as a Captain in the U.S. Marine Corps.
Century Therapeutics Adds Joseph Truitt to Board as Key Biotech Executive
Joseph Truitt, CEO of iECURE Inc. and former CEO of BioSpecifics Technologies, joins Century Therapeutics’ board to bolster its pipeline of diabetes and autoimmune therapies.
PA
Priya Anand · Equities & Earnings Desk · 18 Sept 2026 · 15:27 · 1 min read
This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
PA
Written by
Priya Anand
Equities & Earnings Desk
Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
More from Priya Anand →
